DRIEHAUS CAPITAL MANAGEMENT INC 13D and 13G filings for Cytokinetics, Incorporated:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2022-02-14 09:42 am Sale |
2021-12-31 | 13G | Cytokinetics, Incorporated CYTK |
DRIEHAUS CAPITAL MANAGEMENT INC | 2,327,112 2.770% |
-712,144![]() (-23.43%) |
Filing |